ABC | Volume 111, Nº3, Setembro 2018

Diretrizes Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda Arq Bras Cardiol. 2018; 111(3):436-539 753. Dias JC. [Notes about of Trypanosoma cruzi and yours bio-ecology characteristics with agents of the transmission bymeals]. Rev Soc BrasMed Trop. 2006;39(4):370-5. 754. Pinto AY, Valente Vda C, Coura JR, Valente SA, Junqueira AC, Santos LC, et al. Clinical follow-up of responses to treatment with benznidazol in Amazon: a cohort study of acute Chagas disease. PLoS One. 2013;8(5):e64450. 755. Andrade JP, MarinNeto JA, Paola AA, Vilas-Boas F, Oliveira GM, Bacal F, et al. I Latin American Guidelines for the diagnosis and treatment of Chagas' heart disease: executive summary. Arq Bras Cardiol. 2011;96(6):434-42. 756. da Costa PA, SegattoM, DursoDF, de CarvalhoMoreiraWJ, Junqueira LL, de Castilho FM, et al. Early polymerase chain reaction detection of Chagas disease reactivation in heart transplant patients. J Heart Lung Transplant. 2017;36(7):797-805. 757. Bocchi EA, Fiorelli A; First Guideline Group for Heart Transplantation of the Brazilian Society of Cardiology.. The Brazilian experience with heart transplantation: a multicenter report. J Heart Lung Transplant. 2001;20(6):637-45. 758. QvarnstromY,SchijmanAG,VeronV,AznarC,SteurerF,daSilvaAJ.Sensitive andspecificdetectionofTrypanosomacruziDNAinclinicalspecimensusing amulti-targetreal-timePCRapproach.PLoSNeglTropDis.2012;6(7):e1689. 759. Ginsberg F, Parrillo JE. Fulminant myocarditis. Crit Care Clin. 2013;29(3):465-83. 760. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al; European Society of CardiologyWorking Group onMyocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-48, 48a-48d. 761. Fruhwald F, Lassner D, Fruhwald S, Gross UM, Dapunt O, Schultheiss HP. Immunosuppressive treatment in fulminant myocarditis and gene expression pattern associated with, but no histological confirmation of giant cell myocarditis. ESC Heart Fail. 2017;4(2):190-2. 762. MonteraMW, Mesquita ET, Colafranceschi AS, Oliveira AC Jr, Rabischoffsky A, Ianni BM, et al; Sociedade Brasileira de Cardiologia. I Brazilian guidelines onmyocarditisandpericarditis.ArqBrasCardiol.2013;100(4Suppl1):1-36. 763. Veronese G, Ammirati E, Cipriani M, Frigerio M. Fulminant myocarditis: Characteristics, treatment, and outcomes. Anatol J Cardiol. 2018Mar 13. [Epub ahead of print]. 764. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-10. 765. Dalton A, Shahul S. Cardiac dysfunction in critical illness. Curr Opin Anaesthesiol. 2018;31(2):158-164. 766. Hochstadt A, Meroz Y, Landesberg G. Myocardial dysfunction in severe sepsis and septic shock: more questions than answers? J Cardiothorac Vasc Anesth. 2011;25(3):526-35. 767. Zaky A, Deem S, Bendjelid K, Treggiari MM. Characterization of cardiac dysfunction in sepsis: an ongoing challenge. Shock. 2014;41(1):12-24. 768. Antonucci E, Fiaccadori E, Donadello K, Taccone FS, Franchi F, Scolletta S. Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment. J Crit Care. 2014;29(4):500-11. 769. Masson S, Caironi P, Fanizza C, Carrer S, Caricato A, Fassini P, et al; Albumin Italian Outcome Sepsis Study Investigators. Sequential N-Terminal Pro-B-Type natriuretic peptide and high-sensitivity cardiac troponin measurements during albumin replacement in patients with severe sepsis or septic shock. Crit Care Med. 2016;44(4):707-16. 770. Papanikolaou J, Makris D, Mpaka M, Palli E, Zygoulis P, Zakynthinos E. New insights into the mechanisms involved in B-type natriuretic peptide elevation and its prognostic value in septic patients. Crit Care. 2014;18(3):R94. 771. Abdel-Hady HE, Matter MK, El-Arman MM. Myocardial dysfunction in neonatal sepsis: a tissue Doppler imaging study. Pediatr Crit Care Med. 2012;13(3):318-23. 772. Weng L, Liu YT, Du B, Zhou JF, Guo XX, Peng JM, et al. The prognostic value of left ventricular systolic functionmeasured by tissue Doppler imaging in septic shock. Crit Care. 2012;16(3):R71. 773. Besen BA, Taniguchi LU. Negative fluid balance in sepsis: when and how? Shock. 2017;47(1S Suppl 1):35-40. Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 539